Phio Pharmaceuticals (PHIO) Assets Average (2016 - 2021)
Historic Assets Average for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $29.8 million.
- Phio Pharmaceuticals' Assets Average rose 5500.65% to $29.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $29.8 million, marking a year-over-year increase of 5500.65%. This contributed to the annual value of $11.9 million for FY2020, which is 178.5% up from last year.
- According to the latest figures from Q3 2021, Phio Pharmaceuticals' Assets Average is $29.8 million, which was up 5500.65% from $32.8 million recorded in Q2 2021.
- In the past 5 years, Phio Pharmaceuticals' Assets Average registered a high of $32.8 million during Q2 2021, and its lowest value of $3.6 million during Q1 2018.
- Its 5-year average for Assets Average is $13.5 million, with a median of $11.2 million in 2020.
- As far as peak fluctuations go, Phio Pharmaceuticals' Assets Average plummeted by 6993.6% in 2018, and later soared by 30345.02% in 2019.
- Quarter analysis of 5 years shows Phio Pharmaceuticals' Assets Average stood at $5.1 million in 2017, then soared by 88.84% to $9.6 million in 2018, then dropped by 5.3% to $9.1 million in 2019, then soared by 87.54% to $17.0 million in 2020, then skyrocketed by 75.41% to $29.8 million in 2021.
- Its Assets Average stands at $29.8 million for Q3 2021, versus $32.8 million for Q2 2021 and $24.8 million for Q1 2021.